~75 spots leftby Dec 2025

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

Recruiting in Palo Alto (17 mi)
+6 other locations
Overseen ByHideki Furuya, PhD
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Cedars-Sinai Medical Center
No Placebo Group

Trial Summary

What is the purpose of this trial?To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.

Eligibility Criteria

Participant Groups

Find A Clinic Near You

Research locations nearbySelect from list below to view details:
UT Southwestern Medical Center at DallasDallas, TX
VA Long Beach Healthcare SystemLong Beach, CA
University of Rochester Medical CenterRochester, NY
UCLA Medical CenterLos Angeles, CA
More Trial Locations
Loading ...

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor
Charles RosserLead Sponsor
University of Texas, Southwestern Medical Center at DallasCollaborator
Nara Prefecture Seiwa Medical CenterCollaborator
VA Long Beach Healthcare SystemCollaborator
National Cancer Institute (NCI)Collaborator
Nara Medical UniversityCollaborator
Nonagen Bioscience CorporationIndustry Sponsor
University of California, Los AngelesCollaborator
University of RochesterCollaborator

References